Leptomycin A
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Leptomycin A
Description:
Leptomycin A, a Streptomyces metabolite, is an inhibitor of CRM1 (exportin 1) that blocks CRM1 interaction with nuclear export signals, preventing the nuclear export of a broad range of proteins. Leptomycin A suppresses HIV-1 replication. Less potent than Leptomycin B[1][2].UNSPSC:
12352005Hazard Statement:
H225-H301+H311+H331-H370Target:
Antibiotic; CRM1; HIVType:
Natural ProductsRelated Pathways:
Anti-infection; Membrane Transporter/Ion ChannelApplications:
COVID-19-anti-virusField of Research:
InfectionAssay Protocol:
https://www.medchemexpress.com/leptomycin-a.htmlPurity:
99.0Solubility:
Methanol : 10 mg/mL (ultrasonic;warming)Smiles:
O=C (O) /C=C (C) /C[C@H] (C) [C@@H] (O) [C@H] (C) C ([C@H] (C) /C=C (C) /C=C/C[C@@H] (C) /C=C (C) \C=C\[C@H]1[C@@H] (C) C=CC (O1) =O) =OMolecular Formula:
C32H46O6Molecular Weight:
526.70Precautions:
P210-P233-P240-P241-P242-P243-P260-P261-P264-P270-P271-P280-P302+P352-P303+P361+P353-P304+P340-P308+P311-P330-P361+P364-P370+P378-P403+P233-P403+P235-P405-P501References & Citations:
[1]Kudo, N., et al. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242 (2), 540-547 (1998) .|[2]Wolff B, et al. Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem Biol. 1997 Feb;4 (2) :139-47.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category:
Natural ProductsClinical Information:
No Development ReportedIsoform:
HIV-1CAS Number:
87081-36-5
